Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
Archives of Environmental Contamination and Toxicology|August 1, 1996
Monitoring and estimating concentrations of polychlorinated biphenyls, dioxins, and furans in cattle milk and soils of Rhine-Delta floodplainsA J Hendriks, H Wever, K Olie, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1982
N-(phosphonacetyl)-L-aspartate (PALA) in advanced breast cancer: a phase II trial of the EORTC breast cancer cooperative groupR Paridaens, H T Mouridsen, T Palshof, et al.
Veterinary Microbiology|January 1, 1996
Isolation and characterisation of dog uropathogenic Proteus mirabilis strainsW Gaastra, R A van Oosterom, E W Pieters, et al.
Journal of the National Cancer Institute|May 3, 1995
Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancerM J Piccart, M Gore, W Ten Bokkel Huinink, et al.
Seminars in Surgical Oncology|January 1, 1988
Review of the clinical trials activity of the Soft Tissue and Bone Sarcoma Group of the European Organization for Research and Treatment of CancerV H Bramwell, A Santoro, J Rouesse, et al.
Japanese Journal of Cancer Research : Gann|January 1, 1994
5'-Deoxy-5-fluorouridine increases daunorubicin uptake in multidrug-resistant cells and its activity is related with P-gp 170 expressionS van der Heyden, E Gheuens, W van de Vrie, et al.
Blood|May 1, 1995
Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib studyV D'Hondt, Y Humblet, T Guillaume, et al.
Clinical Chemistry|June 1, 1995
Immunoradiometric method and electrophoretic system compared for quantifying bone alkaline phosphatase in serumV O Van Hoof, M Martin, P Blockx, et al.
Seminars in Oncology|February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, W P Steward, J Verweij, et al.
Cancer Treatment Reports|February 1, 1985
Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma GroupM Gasparini, J Rouesse, A van Oosterom, et al.
Pageof 16